193,881 Orion Corporation A shares converted into B shares

(Thomson Reuters ONE) -



ORION CORPORATION      STOCK EXCHANGE RELEASE 27 JANUARY 2017 at 9.10 a.m.
EET


193,881 Orion Corporation A shares converted into B shares

In accordance with Section 3 of the Articles of Association of Orion
Corporation, 193,881 A shares have been converted into 193,881 B shares. The
conversion has been entered into the Trade Register on 27 January 2017.

The total number of shares in Orion Corporation is 141,257,828 which, after the
conversion, consists of 38,100,273 A shares and 103,157,555 B shares. The number
of votes of the company's shares is after the conversion 865,163,015 .



Orion Corporation



Olli Huotari   Jari Karlson
SVP, Corporate Functions CFO




Contact person:
Terhi Ormio, Vice President, Communications, tel. +358 10 426 4646



Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish pharmaceutical company - a builder of
well-being. Orion develops, manufactures and markets human and veterinary
pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The
company is continuously developing new drugs and treatment methods. The core
therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS)
disorders, oncology and respiratory for which Orion developes inhaled Easyhaler®
pulmonary drugs.

Orion's net sales in 2015 amounted to EUR 1,016 million and the company had
about 3,400 employees. Orion's A and B shares are listed on Nasdaq Helsinki.
Founded in 1917, Orion celebrates its centennial anniversary in 2017.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Orion Oyj via GlobeNewswire

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 27.01.2017 - 08:10 Uhr
Sprache: Deutsch
News-ID 520343
Anzahl Zeichen: 2303

contact information:
Town:

Espoo

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 318 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"193,881 Orion Corporation A shares converted into B shares"
steht unter der journalistisch-redaktionellen Verantwortung von

Orion Oyj (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Orion Receives Positive Phase II Study Results of a New Levodopa Product for Par ...

ESPOO, FINLAND -- (Marketwire) -- 10/24/12 -- ODM-101, a new levodopa product currently developed by Orion for the treatment of Parkinson's disease, has successfully completed Phase II Proof of Concept trial. The key results indicate that ODM-1 ...

200,000 Orion A-shares converted into B-shares ...

Orion clarifies information emanating from Capital Markets Day ...

ORION CORPORATION STOCK EXCHANGE RELEASE 4 DECEMBER 2009 at 17.00 p.m. Orion Corporation is clarifying information emanating from the Capital Markets Day on 1 December 2009 concerning the number of companies that have submitted Abbre ...

Alle Meldungen von Orion Oyj